Back

Brain Aging in Specific Phobia: An ENIGMA-Anxiety Mega-Analysis

Blake, K. V.; Hilbert, K.; Ipser, J. C.; Han, L. K. M.; Bas-Hoogendam, J. M.; Ahs, F.; Bauer, J.; Beesdo-Baum, K.; Björkstrand, J.; Blanco-Hinojo, L.; Böhnlein, J.; Bülow, R.; Cano, M.; Cardoner, N.; Caseras, X.; Dannlowski, U.; Fredrikson, M.; Goossens, L.; Grabe, H. J.; Grotegerd, D.; Hahn, T.; Hamm, A.; Heinig, I.; Herrman, M. J.; Hofmann, D.; Jamalabadai, H.; Jansen, A.; Kindt, M.; Kircher, T.; Klahn, A. L.; Koelkebeck, K.; Krug, A.; Leehr, E. J.; Lotze, M.; Margraf, J.; Muehlhan, M.; Nenadic, I.; Penate, W.; Pittig, A.; Plag, J.; Pujol, J.; Richter, J.; Ridderbusch, I. C.; Rivero, F.;

2025-03-20 psychiatry and clinical psychology
10.1101/2025.03.19.25323474 medRxiv
Show abstract

IntroductionSpecific phobia (SPH) is a prevalent anxiety disorder and may involve advanced biological aging. However, brain age research in psychiatry has primarily examined mood and psychotic disorders. This mega-analysis investigated brain aging in SPH participants within the ENIGMA-Anxiety Working Group. Methods3D brain structural MRI scans from 17 international samples (600 SPH individuals, of whom 504 formally diagnosed and 96 questionnaire-based cases; 1,134 controls; age range: 22-75 years) were processed with FreeSurfer. Brain age was estimated from 77 subcortical and cortical regions with a publicly available ENIGMA brain age model. The brain-predicted age difference (brain-PAD) was calculated as brain age minus chronological age. Linear mixed-effect models examined group differences in brain-PAD and moderation by age. ResultsNo significant group difference in brain-PAD manifested ({beta}diagnosis (SE)=0.37 years (0.43), p=0.39). A negative diagnosis-by-age interaction was identified, which was most pronounced in formally diagnosed SPH ({beta}diagnosis-by-age=-0.08 (0.03), pFDR=0.02). This interaction remained significant when excluding participants with anxiety comorbidities, depressive comorbidities, and medication use. Post-hoc analyses revealed a group difference for formal SPH diagnosis in younger participants (22-35 years; {beta}diagnosis=1.20 (0.60), p<0.05, mixed-effects d (95% confidence interval)=0.14 (0.00-0.28)), but not older participants (36-75 years; {beta}diagnosis=0.07 (0.65), p=0.91). ConclusionsBrain aging did not relate to SPH in the full sample. However, a diagnosis-by-age interaction was observed across analyses, and was strongest in formally diagnosed SPH. Post-hoc analyses showed a subtle advanced brain aging in young adults with formally diagnosed SPH. Taken together, these findings indicate the importance of clinical severity, impairment and persistence, and may suggest a slightly earlier end to maturational processes or subtle decline of brain structure in SPH.

Published in Human Brain Mapping (predicted rank #7) · training set

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.